- Previous Close
0.5890 - Open
0.5900 - Bid --
- Ask --
- Day's Range
0.5720 - 0.5959 - 52 Week Range
0.5700 - 4.2440 - Volume
23,432 - Avg. Volume
164,948 - Market Cap (intraday)
10.957M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in Newport Beach, California.
elevaiskincare.comRecent News: ELAB
Performance Overview: ELAB
Trailing total returns as of 6/21/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ELAB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ELAB
Valuation Measures
Market Cap
10.96M
Enterprise Value
10.19M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.36
Price/Book (mrq)
4.41
Enterprise Value/Revenue
4.66
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-211.42%
Return on Assets (ttm)
-87.78%
Return on Equity (ttm)
-271.67%
Revenue (ttm)
2.18M
Net Income Avi to Common (ttm)
-4.62M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
962.05k
Total Debt/Equity (mrq)
7.07%
Levered Free Cash Flow (ttm)
-3.72M